Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Management of Refractory Pediatric Kaposiform Hemangioendothelioma With Sirolimus and Aspirin.

MacFarland SP, Sullivan LM, States LJ, Bailey LC, Balamuth NJ, Womer RB, Olson TS.

J Pediatr Hematol Oncol. 2018 May;40(4):e239-e242. doi: 10.1097/MPH.0000000000001046.

PMID:
29240034
2.

Identification of Patients With Localized Ewing Sarcoma at Higher Risk for Local Failure: A Report From the Children's Oncology Group.

Ahmed SK, Randall RL, DuBois SG, Harmsen WS, Krailo M, Marcus KJ, Janeway KA, Geller DS, Sorger JI, Womer RB, Granowetter L, Grier HE, Gorlick RG, Laack NNI.

Int J Radiat Oncol Biol Phys. 2017 Dec 1;99(5):1286-1294. doi: 10.1016/j.ijrobp.2017.08.020. Epub 2017 Aug 24.

3.

Surgical treatment of pelvic sarcoma in children: outcomes for twenty six patients.

Kadhim M, Womer RB, Dormans JP.

Int Orthop. 2017 Oct;41(10):2149-2159. doi: 10.1007/s00264-017-3564-5. Epub 2017 Jul 27.

PMID:
28752206
4.

Dosing anticancer drugs in infants: Current approach and recommendations from the Children's Oncology Group's Chemotherapy Standardization Task Force.

Balis FM, Womer RB, Berg S, Winick N, Adamson PC, Fox E; Children's Oncology Group Chemotherapy Standardization Task Force.

Pediatr Blood Cancer. 2017 Nov;64(11). doi: 10.1002/pbc.26636. Epub 2017 May 16.

PMID:
28509433
5.

Comparison of clinical features and outcomes in patients with extraskeletal versus skeletal localized Ewing sarcoma: A report from the Children's Oncology Group.

Cash T, McIlvaine E, Krailo MD, Lessnick SL, Lawlor ER, Laack N, Sorger J, Marina N, Grier HE, Granowetter L, Womer RB, DuBois SG.

Pediatr Blood Cancer. 2016 Oct;63(10):1771-9. doi: 10.1002/pbc.26096. Epub 2016 Jun 14.

6.

Local Control Modality and Outcome for Ewing Sarcoma of the Femur: A Report From the Children's Oncology Group.

Daw NC, Laack NN, McIlvaine EJ, Krailo M, Womer RB, Granowetter L, Grier HE, Marina NM, Bernstein ML, Gebhardt MC, Marcus KJ, Advani SM, Healey JH, Letson GD, Gorlick RG, Randall RL.

Ann Surg Oncol. 2016 Oct;23(11):3541-3547. doi: 10.1245/s10434-016-5269-1. Epub 2016 May 23.

7.

Impact of Two Measures of Micrometastatic Disease on Clinical Outcomes in Patients with Newly Diagnosed Ewing Sarcoma: A Report from the Children's Oncology Group.

Vo KT, Edwards JV, Epling CL, Sinclair E, Hawkins DS, Grier HE, Janeway KA, Barnette P, McIlvaine E, Krailo MD, Barkauskas DA, Matthay KK, Womer RB, Gorlick RG, Lessnick SL, Mackall CL, DuBois SG.

Clin Cancer Res. 2016 Jul 15;22(14):3643-50. doi: 10.1158/1078-0432.CCR-15-2516. Epub 2016 Feb 9.

8.

Pilot Study of Adding Vincristine, Topotecan, and Cyclophosphamide to Interval-Compressed Chemotherapy in Newly Diagnosed Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology Group.

Mascarenhas L, Felgenhauer JL, Bond MC, Villaluna D, Femino JD, Laack NN, Ranganathan S, Meyer J, Womer RB, Gorlick R, Krailo MD, Marina N.

Pediatr Blood Cancer. 2016 Mar;63(3):493-8. doi: 10.1002/pbc.25837. Epub 2015 Nov 18.

9.

Age, Tumor Characteristics, and Treatment Regimen as Event Predictors in Ewing: A Children's Oncology Group Report.

Marina N, Granowetter L, Grier HE, Womer RB, Randall RL, Marcus KJ, McIlvaine E, Krailo M.

Sarcoma. 2015;2015:927123. doi: 10.1155/2015/927123. Epub 2015 Oct 5.

10.

Rapid Protocol Enrollment in Osteosarcoma: A Report From the Children's Oncology Group.

Isakoff MS, Goldsby R, Villaluna D, Krailo MD, Gorlick R, Doski JJ, Womer RB, Janeway KA.

Pediatr Blood Cancer. 2016 Feb;63(2):370-1. doi: 10.1002/pbc.25754. Epub 2015 Sep 16. No abstract available.

11.

Ewing Sarcoma: Current Management and Future Approaches Through Collaboration.

Gaspar N, Hawkins DS, Dirksen U, Lewis IJ, Ferrari S, Le Deley MC, Kovar H, Grimer R, Whelan J, Claude L, Delattre O, Paulussen M, Picci P, Sundby Hall K, van den Berg H, Ladenstein R, Michon J, Hjorth L, Judson I, Luksch R, Bernstein ML, Marec-Bérard P, Brennan B, Craft AW, Womer RB, Juergens H, Oberlin O.

J Clin Oncol. 2015 Sep 20;33(27):3036-46. doi: 10.1200/JCO.2014.59.5256. Epub 2015 Aug 24. Review.

PMID:
26304893
12.

Identification of Discrete Prognostic Groups in Ewing Sarcoma.

Karski EE, McIlvaine E, Segal MR, Krailo M, Grier HE, Granowetter L, Womer RB, Meyers PA, Felgenhauer J, Marina N, DuBois SG.

Pediatr Blood Cancer. 2016 Jan;63(1):47-53. doi: 10.1002/pbc.25709. Epub 2015 Aug 10.

13.

Gene Expression Profiling of Ewing Sarcoma Tumors Reveals the Prognostic Importance of Tumor-Stromal Interactions: A Report from the Children's Oncology Group.

Volchenboum SL, Andrade J, Huang L, Barkauskas DA, Krailo M, Womer RB, Ranft A, Potratz J, Dirksen U, Triche TJ, Lawlor ER.

J Pathol Clin Res. 2015 Apr;1(2):83-94.

14.

Development of curative therapies for Ewing sarcomas by interdisciplinary cooperative groups in Europe.

Bölling T, Braun-Munzinger G, Burdach S, Calaminus G, Craft A, Delattre O, Deley MC, Dirksen U, Dockhorn-Dworniczak B, Dunst J, Engel S, Faldum A, Fröhlich B, Gadner H, Göbel U, Gosheger G, Hardes J, Hawkins DS, Hjorth L, Hoffmann C, Kovar H, Kruseova J, Ladenstein R, Leuschner I, Lewis IJ, Oberlin O, Paulussen M, Potratz J, Ranft A, Rössig C, Rübe C, Sauer R, Schober O, Schuck A, Timmermann B, Tirode F, van den Berg H, van Valen F, Vieth V, Willich N, Winkelmann W, Whelan J, Womer RB.

Klin Padiatr. 2015 May;227(3):108-15. doi: 10.1055/s-0035-1545263. Epub 2015 May 18.

PMID:
25985445
15.

Tumoral TP53 and/or CDKN2A alterations are not reliable prognostic biomarkers in patients with localized Ewing sarcoma: a report from the Children's Oncology Group.

Lerman DM, Monument MJ, McIlvaine E, Liu XQ, Huang D, Monovich L, Beeler N, Gorlick RG, Marina NM, Womer RB, Bridge JA, Krailo MD, Randall RL, Lessnick SL; Children's Oncology Group Ewing Sarcoma Biology Committee.

Pediatr Blood Cancer. 2015 May;62(5):759-65. doi: 10.1002/pbc.25340. Epub 2014 Dec 2.

16.

Comparative evaluation of local control strategies in localized Ewing sarcoma of bone: a report from the Children's Oncology Group.

DuBois SG, Krailo MD, Gebhardt MC, Donaldson SS, Marcus KJ, Dormans J, Shamberger RC, Sailer S, Nicholas RW, Healey JH, Tarbell NJ, Randall RL, Devidas M, Meyer JS, Granowetter L, Womer RB, Bernstein M, Marina N, Grier HE.

Cancer. 2015 Feb 1;121(3):467-75. doi: 10.1002/cncr.29065. Epub 2014 Sep 23.

17.

Clinical and biochemical function of polymorphic NR0B1 GGAA-microsatellites in Ewing sarcoma: a report from the Children's Oncology Group.

Monument MJ, Johnson KM, McIlvaine E, Abegglen L, Watkins WS, Jorde LB, Womer RB, Beeler N, Monovich L, Lawlor ER, Bridge JA, Schiffman JD, Krailo MD, Randall RL, Lessnick SL.

PLoS One. 2014 Aug 5;9(8):e104378. doi: 10.1371/journal.pone.0104378. eCollection 2014.

18.

Proactive enteral tube feeding in pediatric patients undergoing chemotherapy.

Sacks N, Hwang WT, Lange BJ, Tan KS, Sandler ES, Rogers PC, Womer RB, Pietsch JB, Rheingold SR.

Pediatr Blood Cancer. 2014 Feb;61(2):281-5. doi: 10.1002/pbc.24759. Epub 2013 Sep 9.

PMID:
24019241
19.

Histologic and clinical characteristics can guide staging evaluations for children and adolescents with rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee.

Weiss AR, Lyden ER, Anderson JR, Hawkins DS, Spunt SL, Walterhouse DO, Wolden SL, Parham DM, Rodeberg DA, Kao SC, Womer RB.

J Clin Oncol. 2013 Sep 10;31(26):3226-32. doi: 10.1200/JCO.2012.44.6476. Epub 2013 Aug 12.

20.

Biomarkers in Ewing Sarcoma: The Promise and Challenge of Personalized Medicine. A Report from the Children's Oncology Group.

Shukla N, Schiffman J, Reed D, Davis IJ, Womer RB, Lessnick SL, Lawlor ER; COG Ewing Sarcoma Biology Committee.

Front Oncol. 2013 Jun 6;3:141. doi: 10.3389/fonc.2013.00141. eCollection 2013.

21.

Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group.

Womer RB, West DC, Krailo MD, Dickman PS, Pawel BR, Grier HE, Marcus K, Sailer S, Healey JH, Dormans JP, Weiss AR.

J Clin Oncol. 2012 Nov 20;30(33):4148-54. doi: 10.1200/JCO.2011.41.5703. Epub 2012 Oct 22. Erratum in: J Clin Oncol. 2015 Mar 1;33(7):814. Dosage error in article text.

22.

Investigation of the insulin-like growth factor-1 signaling pathway in localized Ewing sarcoma: a report from the Children's Oncology Group.

Borinstein SC, Barkauskas DA, Krailo M, Scher D, Scher L, Schlottmann S, Kallakury B, Dickman PS, Pawel BR, West DC, Womer RB, Toretsky JA.

Cancer. 2011 Nov 1;117(21):4966-76. doi: 10.1002/cncr.26112. Epub 2011 Apr 8.

23.

Ewing tumors that do not overexpress BMI-1 are a distinct molecular subclass with variant biology: a report from the Children's Oncology Group.

Cooper A, van Doorninck J, Ji L, Russell D, Ladanyi M, Shimada H, Krailo M, Womer RB, Hsu JH, Thomas D, Triche TJ, Sposto R, Lawlor ER.

Clin Cancer Res. 2011 Jan 1;17(1):56-66. doi: 10.1158/1078-0432.CCR-10-1417. Epub 2010 Nov 3.

24.

Outpatient high-dose methotrexate: proceed with extreme caution, if at all.

Womer RB.

Pediatr Blood Cancer. 2010 Dec 15;55(7):1250-1. doi: 10.1002/pbc.22847. No abstract available.

PMID:
20981687
25.

Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology Group.

van Doorninck JA, Ji L, Schaub B, Shimada H, Wing MR, Krailo MD, Lessnick SL, Marina N, Triche TJ, Sposto R, Womer RB, Lawlor ER.

J Clin Oncol. 2010 Apr 20;28(12):1989-94. doi: 10.1200/JCO.2009.24.5845. Epub 2010 Mar 22.

26.

Ewing's sarcoma.

Balamuth NJ, Womer RB.

Lancet Oncol. 2010 Feb;11(2):184-92. doi: 10.1016/S1470-2045(09)70286-4. Review.

PMID:
20152770
27.

Genitourinary rhabdomyosarcoma: which treatment, how much, and when?

Wu HY, Snyder HM 3rd, Womer RB.

J Pediatr Urol. 2009 Dec;5(6):501-6. doi: 10.1016/j.jpurol.2009.06.011. Epub 2009 Jul 28. Review.

PMID:
19640790
28.

Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology Group.

Chou AJ, Kleinerman ES, Krailo MD, Chen Z, Betcher DL, Healey JH, Conrad EU 3rd, Nieder ML, Weiner MA, Wells RJ, Womer RB, Meyers PA; Children's Oncology Group.

Cancer. 2009 Nov 15;115(22):5339-48. doi: 10.1002/cncr.24566.

29.

Imaging guidelines for children with Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group Bone Tumor Committee.

Meyer JS, Nadel HR, Marina N, Womer RB, Brown KL, Eary JF, Gorlick R, Grier HE, Randall RL, Lawlor ER, Lessnick SL, Schomberg PJ, Kailo MD.

Pediatr Blood Cancer. 2008 Aug;51(2):163-70. doi: 10.1002/pbc.21596.

PMID:
18454470
30.

Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.

Meyers PA, Schwartz CL, Krailo MD, Healey JH, Bernstein ML, Betcher D, Ferguson WS, Gebhardt MC, Goorin AM, Harris M, Kleinerman E, Link MP, Nadel H, Nieder M, Siegal GP, Weiner MA, Wells RJ, Womer RB, Grier HE; Children's Oncology Group.

J Clin Oncol. 2008 Feb 1;26(4):633-8. doi: 10.1200/JCO.2008.14.0095.

PMID:
18235123
31.

Molecular diagnosis of ewing family tumors: too many fusions... ?

Barr FG, Womer RB.

J Mol Diagn. 2007 Sep;9(4):437-40. Epub 2007 Jul 25. No abstract available.

32.

Bladder/prostate rhabdomyosarcoma: miles to go before we sleep.

Womer RB, Snyder HM.

J Urol. 2006 Oct;176(4 Pt 1):1278-9. No abstract available.

PMID:
16952611
33.

Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma.

Malogolowkin MH, Katzenstein H, Krailo MD, Chen Z, Bowman L, Reynolds M, Finegold M, Greffe B, Rowland J, Newman K, Womer RB, London WB, Castleberry RP.

J Clin Oncol. 2006 Jun 20;24(18):2879-84.

PMID:
16782927
34.

Prognostic factors in children with extragonadal malignant germ cell tumors: a pediatric intergroup study.

Marina N, London WB, Frazier AL, Lauer S, Rescorla F, Cushing B, Malogolowkin MH, Castleberry RP, Womer RB, Olson T.

J Clin Oncol. 2006 Jun 1;24(16):2544-8.

PMID:
16735707
35.

Preventing organ-specific chemotherapy toxicity.

Ginsberg JP, Womer RB.

Eur J Cancer. 2005 Nov;41(17):2690-700. Epub 2005 Oct 20. Review.

PMID:
16243514
36.

Long-term follow-up and prognosis of orbital apex syndrome resulting from nasopharyngeal rhabdomyosarcoma.

Shindler KS, Liu GT, Womer RB.

Am J Ophthalmol. 2005 Aug;140(2):236-41.

PMID:
16023064
37.

Amifostine does not protect against the ototoxicity of high-dose cisplatin combined with etoposide and bleomycin in pediatric germ-cell tumors: a Children's Oncology Group study.

Marina N, Chang KW, Malogolowkin M, London WB, Frazier AL, Womer RB, Rescorla F, Billmire DF, Davis MM, Perlman EJ, Giller R, Lauer SJ, Olson TA; Children's Oncology Group.

Cancer. 2005 Aug 15;104(4):841-7.

38.

Predicting cisplatin ototoxicity in children: the influence of age and the cumulative dose.

Li Y, Womer RB, Silber JH.

Eur J Cancer. 2004 Nov;40(16):2445-51.

PMID:
15519518
39.

Early molecular detection of central nervous system relapse in a child with systemic anaplastic large cell lymphoma: case report and review of the literature.

Armstrong G, Szallasi A, Biegel JA, Shurtleff S, Bilaniuk LT, Womer RB, Choi JK.

Pediatr Blood Cancer. 2005 Apr;44(4):400-6. Review.

PMID:
15515044
40.

Evolution of a Rapid Hydration Protocol.

Tracy E, DiTaranto S, Womer RB.

J Pediatr Oncol Nurs. 2004 Jan;21(1):22-6.

PMID:
15058403
41.

An examination of outcome measures to assess functional mobility in childhood survivors of osteosarcoma.

Marchese VG, Ogle S, Womer RB, Dormans J, Ginsberg JP.

Pediatr Blood Cancer. 2004 Jan;42(1):41-5.

PMID:
14752793
42.

Ewing sarcoma/primitive neuroectodermal tumor of the chest wall: impact of initial versus delayed resection on tumor margins, survival, and use of radiation therapy.

Shamberger RC, LaQuaglia MP, Gebhardt MC, Neff JR, Tarbell NJ, Marcus KC, Sailer SL, Womer RB, Miser JS, Dickman PS, Perlman EJ, Devidas M, Linda SB, Krailo MD, Grier HE, Granowetter L.

Ann Surg. 2003 Oct;238(4):563-7; discussion 567-8.

43.

Volumetric considerations in radiotherapy for pediatric parameningeal rhabdomyosarcomas.

Chen C, Shu HK, Goldwein JW, Womer RB, Maity A.

Int J Radiat Oncol Biol Phys. 2003 Apr 1;55(5):1294-9. Review.

PMID:
12654440
44.

Multidisciplinary systems approach to chemotherapy safety: rebuilding processes and holding the gains.

Womer RB, Tracy E, Soo-Hoo W, Bickert B, DiTaranto S, Barnsteiner JH.

J Clin Oncol. 2002 Dec 15;20(24):4705-12.

PMID:
12488417
45.

Children from ethnic minorities have benefited equally as other children from contemporary therapy for rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study Group.

Baker KS, Anderson JR, Lobe TE, Wharam MD, Qualman SJ, Raney RB, Ruymann FB, Womer RB, Meyer WH, Link MP, Crist WM.

J Clin Oncol. 2002 Nov 15;20(22):4428-33.

PMID:
12431964
46.

Rhabdomyosarcoma of the parotid region occurring in childhood and adolescence. A report from the Intergroup Rhabdomyosarcoma Study Group.

Walterhouse DO, Pappo AS, Baker KS, Parham DM, Anderson JR, Donaldson SS, Paidas CN, Womer RB, Crist WM.

Cancer. 2001 Dec 15;92(12):3135-46.

PMID:
11753993
48.

Pediatric bone tumors: osteosarcoma ewing's sarcoma, and chondrosarcoma associated with multiple hereditary osteochondromatosis.

Pierz KA, Womer RB, Dormans JP.

J Pediatr Orthop. 2001 May-Jun;21(3):412-8. Review. No abstract available.

PMID:
11371830
49.

Rhabdomyosarcoma and soft tissue sarcoma in childhood.

Womer RB, Pressey JG.

Curr Opin Oncol. 2000 Jul;12(4):337-44. Review.

PMID:
10888419

Supplemental Content

Loading ...
Support Center